-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Sonnet BioTherapeutics Holdings, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2024.
- Sonnet BioTherapeutics Holdings, Inc. Operating Lease, Payments for the quarter ending June 30, 2022 was $24.7K, a 3.31% decline year-over-year.
- Sonnet BioTherapeutics Holdings, Inc. annual Operating Lease, Payments for 2024 was $93.6K, a 18.1% increase from 2023.
- Sonnet BioTherapeutics Holdings, Inc. annual Operating Lease, Payments for 2023 was $79.3K, a 19.2% decline from 2022.
- Sonnet BioTherapeutics Holdings, Inc. annual Operating Lease, Payments for 2022 was $98.1K, a 3.36% decline from 2021.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)